Related Experiment Video

Updated: Jun 10, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it

Carmen Chak-Lui Wong1, Chun-Ming Wong, Sandy Leung-Kuen Au

  • 1Liver Cancer and Hepatitis Research Laboratory, Department of Pathology, University of Hong Kong, Pokfulam, Hong Kong.

Insights

Hepatocellular carcinoma (HCC) metastasis is a major cause of death. Targeting the RhoGTPases/Rho-effector pathway, crucial for cell movement, offers potential new therapies for advanced liver cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Hepatocellular carcinoma (HCC) presents a significant global health challenge due to its high mortality rate.
  • Tumor metastasis is the primary driver of liver failure, recurrence, and mortality in HCC patients.
  • Current therapeutic options for advanced HCC and its metastasis remain limited and largely ineffective.

Purpose of the Study:

  • To review the fundamental mechanisms of cancer metastasis and cell migration, with a specific emphasis on HCC.
  • To elucidate the role of the RhoGTPases/Rho-effector pathway in mediating HCC metastasis.
  • To explore potential therapeutic strategies targeting this pathway for HCC treatment.

Main Methods:

  • Literature review focusing on cancer metastasis, cell movement, and the RhoGTPases/Rho-effector signaling pathway.
  • Analysis of upstream regulators, RhoGTPases, Rho-effectors, and their downstream targets in the context of HCC metastasis.
  • Discussion of therapeutic implications derived from understanding this signaling cascade.

Main Results:

  • The RhoGTPases/Rho-effector pathway is critically involved in orchestrating cytoskeletal reorganization, a key process in HCC cell migration and metastasis.
  • Specific RhoGTPases and their effectors play significant roles in the metastatic cascade of hepatocellular carcinoma.
  • Understanding the intricate signaling network of RhoGTPases/Rho-effectors is vital for developing effective anti-metastatic therapies.

Conclusions:

  • The RhoGTPases/Rho-effector signaling pathway is a pivotal regulator of HCC metastasis.
  • Targeting this pathway holds promise for developing novel therapeutic interventions against advanced HCC.
  • Further in-depth research into this complex signaling network is necessary to translate findings into clinical applications.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker proteins that...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...